Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.750
-0.050 (-2.78%)
At close: Jul 14, 2026, 4:00 PM EDT
1.787
+0.037 (2.11%)
After-hours: Jul 14, 2026, 7:49 PM EDT
Caribou Biosciences Employees
Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year.
Employees
97
Change (1Y)
-50
Growth (1Y)
-34.01%
Revenue / Employee
$115,495
Profits / Employee
-$1,373,392
Market Cap
173.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 97 | -50 | -34.01% |
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Humacyte | 184 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| Alpha Cognition | 71 |
| Tenaya Therapeutics | 70 |
| Acumen Pharmaceuticals | 61 |
| Q32 Bio | 22 |
CRBU News
- 14 days ago - Caribou Biosciences Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 15 days ago - Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 27 days ago - Caribou Biosciences Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Caribou Biosciences presents ANTLER trial results at EHA - TheFly
- 4 weeks ago - Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 - GlobeNewsWire
- 4 weeks ago - Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Caribou Biosciences Slides: Corporate presentation - Filings
- 5 weeks ago - Caribou Biosciences Proxy statement: Proxy filing - Filings